NEXT BIOMEDICAL picked for 2nd round of '2024 Export Voucher' program

NEXT BIOMEDICAL has been selected to participate in the second round of the “2024 Export Voucher” program.

The Export Voucher program, operated by the Ministry of SMEs and Startups, provides 14 overseas marketing services, including design development, public relations, buyer discovery, and international transportation, to support SMEs in entering overseas markets. In the second round of the program, 4,441 companies applied, and 652 were selected, recording a 6.8-to-1 competition ratio.

NEXT BIOMEDICAL will receive a voucher worth 100 million won ($74,650) and will use various export services until March 31, 2025.

NEXT BIOMEDICAL is a bio-solution company that develops innovative therapeutic materials based on polymer and drug-delivery system technologies. The company commercializes its products in domestic and overseas markets and has been recognized for its technology and innovation through certifications by the Ministry of Food and Drug Safety, European CE, and U.S. FDA. In addition, it has established a cooperation system with Medtronic, the world's largest medical device company.

“NEXT BIOMEDICAL’s selection for the Export Voucher program is expected to further accelerate our entry into overseas markets,” Next BiomedicaL CEO Lee Don-haeng said.